Transaction · 0001493152-26-045140

Meikle Phillip Terry II

Meikle Phillip Terry II, DIR, reported a transaction classified as grant at Bone Biologics Corp involving 113896.000000 shares for an estimated $0.00. Reported holdings after the transaction were 113896.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
BBLGBone Biologics Corp
Filing timeSep 30
Trade dateSep 28, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

BBLG price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BBLG since 2026-09-30Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001493152-26-045140
Non-Employee Stock Option
Transaction date
Sep 28, 2026
Filed Sep 30, 2026, 09:09 PM · 2d delay
Shares
113k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
113k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests infour eq…

  2. F2

    This option is fully exercisable as of the date of this report.

Original filing · 0001493152-26-045140
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BBLG